BRUSSELS À JOUR - More Pills to Swallow – Antitrust Scrutiny in the Pharmaceutical Sector remains High
2 December 2024
HENSOLDT AG today successfully placed 10.5 million new shares following a capital increase via an accelerated bookbuilding process with institutional investors, with the exclusion of existing shareholders' subscription rights. The gross proceeds of approx. EUR 241 million will be used to partially finance the purchase price for the acquisition of ESG Elektroniksystem- und Logistik GmbH which was signed on 5 December 2023.
The Federal Republic of Germany, acting indirectly through Kreditanstalt für Wiederaufbau (KfW), has acquired new shares in the capital increase pro rata to their 25.1% shareholding.
The prospectus-free admission of the new shares to trading in the sub-segment of the regulated market with additional post-admission obligations (Prime Standard) at the Frankfurt Stock Exchange is expected to take place on 12 December 2023.
Hengeler Mueller team for HENSOLDT AG
Capital Markets/Corporate: Dirk Busch (partner, lead), Caspar Haarmann (counsel, both Dusseldorf), Pascal Brandt (Dusseldorf/Frankfurt), Matthias Mayer (Dusseldorf, both associates),
FDI: Christian Schwandtner (partner), Jan Schülting, Barbara Boytinck, Susanne Struth (all associates, all Dusseldorf),
Antitrust: Alf-Henrik Bischke (partner), Anja Balitzki (counsel), Daniel Higer (associate, all Dusseldorf).
